Uttam Yashwant Patil
Vermögen: 102 123 $ am 31.05.2026
Vermögen: 102 123 $ am 31.05.2026
Uttam Yashwant Patil currently works at AiBtl BioPharma, Inc., as Co-Chief Executive Officer from 2025, ABVC BioPharma, Inc., as Chief Executive & Financial Officer from 2023, Biokey, Inc., as Chief Operating & Scientific Officer from 2023, and Rgene Corp., as Manager-Research & Development from 2023.
Dr. Patil received his doctorate degree from National Tsing-Hua University and undergraduate degree and graduate degree from the University of Pune.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABVC BIOPHARMA, INC. 0,28 % | 27.02.2026 | 72.428 ( 0,28 % ) | 102 123 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ABVC BIOPHARMA, INC. | Vorstandsvorsitzender | 23.06.2023 |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Geschäftsführer | 01.05.2023 |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2023 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
National Tsing-Hua University
National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pune
University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABVC BioPharma, Inc.
ABVC BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops drugs and medical devices in the fields of oncology, ophthalmology and central nervous system | Health Technology |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen